Latest Market Disruption News

Sayona Mining has secured shareholder approval for its merger with Piedmont Lithium, with completion slated for August 30, 2025. The deal promises to reshape the lithium supply landscape and unlock significant growth potential.

Vital Metals Limited has voluntarily suspended trading of its shares pending a key announcement on a capital raise, following an ASX price and volume query.

HUB24 Limited reported robust FY25 results, driven by a 34% surge in platform funds under administration and a 44% rise in underlying net profit after tax. The company expanded its adviser base and boosted dividends, reinforcing its leadership in Australia's wealth management technology sector.

Santana Minerals has raised A$63 million through a fully underwritten placement and a Share Purchase Plan to fast-track development of its Bendigo-Ophir Gold Project, attracting strong support from international and domestic investors.

HeraMED Limited has resumed trading on the ASX following the release of its quarterly reports and a significant capital raising announcement, marking a pivotal moment for the medical device company.

PIES Holding Co and Activeport Group have launched a strategic joint venture to integrate AI-driven low-code/no-code tools with advanced network orchestration software, aiming to transform telecommunications and data centre operations globally.

MotorCycle Holdings Limited (ASX, MTO) has agreed to acquire Peter Stevens Motorcycles and Harley Heaven, expanding its footprint across Australia with 15 new dealerships and enhancing its digital retail capabilities.

Rapid Critical Metals Limited has revised its timetable for the consolidation of issued capital, setting key dates from early June to late July 2025. The update outlines shareholder meeting schedules, trading suspensions, and the phased resumption of trading.

Universal Biosensors has requested a voluntary suspension of its shares on the ASX, pending details of a proposed capital raising. The suspension is expected to last until the end of June or until the announcement is made.

Simble Solutions Limited has voluntarily suspended its ASX trading pending a capital raising announcement, signaling a significant funding move for the software company.

The Takeovers Panel has imposed interim restrictions on shares issued in Emu NL's recent placement, halting any trading by subscribers pending further review.

AFT Pharmaceuticals reported a 6% revenue increase to NZ$208 million in FY25, driven by strong ANZ growth and expanding international presence. The company targets NZ$300 million revenue by FY27 amid ongoing R&D and new product launches.